Login/Sign Up
₹6314*
MRP ₹7700
18% off
₹6545*
MRP ₹7700
15% CB
₹1155 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Kintsugi 150 Injection 1's is used to treat Breast Cancer and Stomach Cancer. Kintsugi 150 Injection 1's contains Trastuzumab, which works by attaching itself to the HER2 proteins so that the cancer cells are no longer stimulated to grow. It also helps the body's immune system to destroy breast cancer cells. It should not be taken during pregnancy as it might cause fetal harm. Inform your doctor immediately if you are conceiving while on therapy. Advise women not to breastfeed while taking Kintsugi 150 Injection 1's.
Provide Delivery Location
Whats That
About Kintsugi 150 Injection 1's
Kintsugi 150 Injection 1's is an anti-cancer medicine used in the treatment of HER2-positive Breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.
Kintsugi 150 Injection 1's contains Trastuzumab as an active ingredient, which belongs to the class of monoclonal antibodies. It works by inhibiting the abnormal growth of cancer cells and, finally, causes the initiation of programmed cell death.
Kintsugi 150 Injection 1's may cause certain side effects such as abdominal pain, chills, diarrhoea, fatigue, nausea, back pain, bone pain, edema, insomnia, fever, dizziness, headache, vomiting, cough, rash, and injection site reactions. If the side effects persist or bother you, please consult your doctor. Kintsugi 150 Injection 1's will be administered by a trained doctor. Hence, do not self-administer.
Avoid taking it and inform your doctor if you are allergic to Kintsugi 150 Injection 1's or its components. Inform your doctor if you have any cardiovascular conditions, lung problems, or liver/kidney disease, as it can cause adverse effects. Kintsugi 150 Injection 1's is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.
Uses of Kintsugi 150 Injection 1's
Directions for Use
Medicinal Benefits
Kintsugi 150 Injection 1's contains Trastuzumab, which is used for treating patients with HER2-positive breast cancer and HER2-positive metastatic gastroesophageal adenocarcinoma. This medicine works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in the mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of programmed cell death.
How Kintsugi 150 Injection 1's Works
Storage
What if I have taken an overdose of Kintsugi 150 Injection 1's
Drug Warnings
Kintsugi 150 Injection 1's should be avoided if you are allergic to it or any other components of this medicine. Inform your doctor if you have any lung problems, cardiovascular conditions or liver/kidney disease, as it can cause adverse effects. Kintsugi 150 Injection 1's may cause left ventricular ejection fraction, cardiomyopathy, pulmonary toxicity, exacerbations of chemotherapy-induced neutropenia, and hypersensitivity reactions during the treatment. Hence, careful observation should be performed for any reactions in the patient. Kintsugi 150 Injection 1's may cause embryo-fetal toxicity. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Breastfeeding should be discontinued in nursing mothers during the treatment. Kintsugi 150 Injection 1's is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
by Others
by Others
by Others
by Others
by Others
Product Substitutes
Alcohol
Unsafe
Avoid consumption of alcohol as it may cause serious side effects.
Pregnancy
Unsafe
Kintsugi 150 Injection 1's is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Kintsugi 150 Injection 1's. Use reliable methods of birth control while on treatment with Kintsugi 150 Injection 1's.
Breast Feeding
Unsafe
Avoid nursing your child while on treatment with Kintsugi 150 Injection 1's as it can cause serious side effects to the baby.
Driving
Not applicable
-
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Kintsugi 150 Injection 1's. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
Limited data are available on the effect of Kintsugi 150 Injection 1's in kidney-impaired patients. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor.
Children
Unsafe
Kintsugi 150 Injection 1's is not recommended for use in children as the safety and efficacy are not established.
Have a query?
Kintsugi 150 Injection 1's is used to treat Breast Cancer and Stomach Cancer.
Kintsugi 150 Injection 1's contains Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.
Inform your doctor whether you have received any other cancer treatment. Kintsugi 150 Injection 1's may cause a decrease in left ventricular ejection fraction, cardiomyopathy, hypersensitivity reactions, pulmonary toxicity, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Kintsugi 150 Injection 1's.
Consult the doctor immediately, if you experience symptoms of an infection, such as a high temperature, chills, or feeling unwell despite a normal temperature. It could be due to a reduced white blood cell count caused by Kintsugi 150 Injection 1's, increasing your risk of severe infections. Additionally, swollen feet or ankles, stomach pain, or lower back pain may indicate heart problems.
It is recommended to wait at least 6 months after completing Kintsugi 150 Injection 1's therapy before trying to get pregnant. This is because the medication can remain in the body for some time and may potentially affect pregnancy. However, it is essential to consult the doctor for personalized advice and to ensure that it is safe for you to become pregnant after this treatment.
The duration of treatment with Kintsugi 150 Injection 1's will depend on an individual treatment plan, which your doctor will determine based on your specific condition. It may vary based on personal medical conditions and how you respond to the therapy. In some cases, the treatment duration may be shorter or longer. Always attend follow-up appointments as instructed by the doctor for effective treatment.
Fasting is not typically required before administering Kintsugi 150 Injection 1's. However, it is always best to follow the doctor's specific instructions regarding preparations before treatment. If fasting is necessary, your doctor will provide detailed guidance.
Kintsugi 150 Injection 1's should be administered through subcutaneous (SC) or intravenous (IV) routes by the doctor or nurse. Do not self-administer.
Kintsugi 150 Injection 1's should not be administered to patients with HER2-negative cancer cells as it is a monoclonal antibody that specifically targets a protein called human epidermal growth factor receptor 2 (HER2), which is present in high amounts on the surface of specific cancer cells.
The doctor may recommend heart investigations while you are taking Kintsugi 150 Injection 1's as it may potentially affect heart function. It has been associated with heart-related side effects, including a decrease in left ventricular ejection fraction, which could lead to heart failure in some patients. Monitoring heart health helps detect any issues early, ensuring prompt action to manage the risk. Always follow the doctor's recommendations for regular check-ups during treatment.
During treatment with Kintsugi 150 Injection 1's for advanced-stage disease, cardiac monitoring was conducted every 3 to 8 months for up to 2 years. However, the doctor will adjust the frequency of heart investigations based on your specific condition and response to treatment. It's essential to follow their advice for optimal monitoring and early detection of any heart-related issues.
The side effects of Kintsugi 150 Injection 1's include abdominal pain, chills, headache, diarrhoea, fatigue, nausea, back pain, bone pain, oedema, insomnia, fever, dizziness, vomiting, cough, rash, and injection site reactions. Consult the doctor if any of these side effects persist or worsen.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information